Drug Type Monoclonal antibody |
Synonyms Huvap, BTT-1002 |
Target |
Action inhibitors |
Mechanism VAP-1 inhibitors(Amine oxidase, copper containing inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Vapaliximab | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Phase 1 | - | - | |
| Asthma | Phase 1 | - | - | |
| Asthma | Phase 1 | - | - | |
| Graft Rejection | Phase 1 | - | - | |
| Graft Rejection | Phase 1 | - | - | |
| Graft Rejection | Phase 1 | - | - | |
| Inflammation | Phase 1 | Finland | - | |
| Inflammation | Phase 1 | - | - | |
| Inflammation | Phase 1 | - | - | |
| Inflammation | Phase 1 | - | - |






